OTUD3 and metastatic malignant neoplasm in the lymph nodes: OTUD3 was significantly down-regulated in heavy smokers compared to non-smoking or normal tissues, and low OTUD3 expression was significantly associated with adverse clinicopathological features, including tumor size, lymph node metastasis, pathological grading, and clinical staging [61].